Published in Pharma Law Weekly, November 2nd, 2004
According to researchers in Brazil, "Impaired parasympathetic modulation increases the risk for sudden death in patients with heart diseases. Therefore, cholinergic stimulation may have a potential protective role. The aim of [our] study was to verify the effects of pyridostigmine bromide, a reversible cholinesterase inhibitor, on heart rate (HR), blood pressure (BP), HR and BP variability, and baroreflex sensitivity (BS).
P.P. Soares and colleagues of the University of Sao Paulo wrote, "Male Wistar rats were divided in two groups: (1)...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly